If there is one dream children born into African poverty and people mired in the ennui of the first world share, it would be how significantly life would improve with the absence of mosquitoes. That dream may become reality.
An experimental vaccine from GlaxoSmithKline reduced the risk of African children getting malaria by 50 percent in a major clinical trial. Unfortunately, the vaccine likely won’t be ready until 2015.
Launched in July, KAMMOK™ is already one of the top 20 highest-funded campaigns in Kickstarter history. The adventure brand does good, too: It donates 20% of profits to humanitarian aid. Ty Clark introduces you to the founder, and to the idea.
A new PSA from GOOD Magazine uses the clever conceit of a sex tape to warn of the dangers malaria presents in developing nations. But who exactly is the PSA aimed for? Certainly not the people who will benefit the most from their good intentions.